dbACP: A Comprehensive Database of Anti-Cancer Peptides

97 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp02379 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 91.8% cell viability at 12.5 µM
dbacp02380 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 84.1% cell viability at 25 µM
dbacp02381 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 76.3% cell viability at 50 µM
dbacp02382 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 71.5 % cell viability at 75 µM
dbacp02383 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 54.2 % cell viability at 100 µM
dbacp02384 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 87.3 % cell viability at 25 µM
dbacp02385 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 75.6 % cell viability at 50 µM
dbacp02386 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 62.8 % cell viability at 75 µM
dbacp02387 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 54.3 % cell viability at 100 µM
dbacp02388 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 48.6 % cell viability at 100 µM
dbacp02389 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 72.1 % cell viability at 12.5 µM
dbacp02390 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 63.3 % cell viability at 25 µM
dbacp02391 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 49.7 % cell viability at 50 µM
dbacp02392 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 41.1 % cell viability at 75 µM
dbacp02393 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 35.2 % cell viability at 100 µM
dbacp04487 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay U-937 Lymphoma cancer IC50 : >150 µg/ml
dbacp04488 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay 8402 Leukemia cancer IC50 : >150 µg/ml
dbacp04489 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay SSKT-1 Hematopoietic cancer IC50 : >150 µg/ml
dbacp04490 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Daudi Colon cancer IC50 : >150 µg/ml
dbacp04491 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MLA Leukemia cancer IC50 : >150 µg/ml
dbacp04492 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Raji Lymphoma cancer IC50 : >150 µg/ml
dbacp04493 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay K-562 Leukemia cancer IC50 : >150 µg/ml
dbacp04494 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay CHP-100 Ewing sarcoma IC50 : >200 µg/ml
dbacp04495 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MCF-7 Breast cancer IC50 : >200 µg/ml
dbacp04496 Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay PC-3 Prostate cancer IC50 : >200 µg/ml
dbacp04505 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay U-937 Lymphoma cancer IC50 : 16 µg/ml
dbacp04506 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay 8402 Leukemia cancer IC50 : 18 µg/ml
dbacp04507 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay SSKT-1 Hematopoietic cancer IC50 : 23 µg/ml
dbacp04508 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Daudi Lung cancer IC50 : 30 µg/ml
dbacp04509 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MLA Leukemia cancer IC50 : 34 µg/ml
dbacp04510 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Raji Lymphoma cancer IC50 : 20 µg/ml
dbacp04511 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay K-562 Leukemia cancer IC50 : 40 µg/ml
dbacp04512 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay CHP-100 Ewing sarcoma IC50 : 45 µg/ml
dbacp04513 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MCF-7 Breast cancer IC50 : 49 µg/ml
dbacp04514 Magainin A AIGKFLHSAKKFGKAFVGEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay PC-3 Prostate cancer IC50 : 53 µg/ml
dbacp04515 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay U-937 Lymphoma cancer IC50 : 17 µg/ml
dbacp04516 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay 8402 Leukemia cancer IC50 : 12 µg/ml
dbacp04517 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay SSKT-1 Hematopoietic cancer IC50 : 27 µg/ml
dbacp04518 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Daudi Ovarian cancer IC50 : 28 µg/ml
dbacp04519 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MLA Leukemia cancer IC50 : 30 µg/ml
dbacp04520 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Raji Lymphoma cancer IC50 : 23 µg/ml
dbacp04521 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay K-562 Leukemia cancer IC50 : 32 µg/ml
dbacp04522 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay CHP-100 Ewing sarcoma IC50 : 32 µg/ml
dbacp04523 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MCF-7 Breast cancer IC50 : 37 µg/ml
dbacp04524 Magainin B GIGKFLHAAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay PC-3 Prostate cancer IC50 : 41 µg/ml
dbacp04531 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay U-937 Lymphoma cancer IC50 : 19 µg/ml
dbacp04532 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay 8402 Leukemia cancer IC50 : 16 µg/ml
dbacp04533 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay SSKT-1 Hematopoietic cancer IC50 : 29 µg/ml
dbacp04534 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Daudi Renal cancer IC50 : 38 µg/ml
dbacp04535 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MLA Leukemia cancer IC50 : 33 µg/ml
dbacp04536 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Raji Lymphoma cancer IC50 : 25 µg/ml
dbacp04537 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay K-562 Leukemia cancer IC50 :37 µg/ml
dbacp04538 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay CHP-100 Ewing sarcoma IC50 : 39 µg/ml
dbacp04539 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MCF-7 Breast cancer IC50 : 42 µg/ml
dbacp04540 Magainin G GIGKFLHSAKKFAKAFVAEIMNS African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay PC-3 Prostate cancer IC50 : 47 µg/ml
dbacp05743 PTPRJ-pep19 CHHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 4.5 ± 0.1.4% cell growth inhibition at 160 µM
dbacp05744 PTPRJ-pep19 CHHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 19 ± 2.82% cell growth inhibition at 160 µM
dbacp05745 PTPRJ-pep19.0 CHHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 4 ± 1.4% cell growth inhibition at 160 µM
dbacp05746 PTPRJ-pep19.2 CAHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 16.5 ± 2.12% cell growth inhibition at 160 µM
dbacp05747 PTPRJ-pep19.2 CAHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 30 ± 2.82% cell growth inhibition at 160 µM
dbacp05748 PTPRJ-pep19.2 CAHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 32.0 ± 4.2% cell growth inhibition at 160 µM
dbacp05749 PTPRJ-pep19.3 CHANLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 28 ± 5.5% cell growth inhibition at 160 µM
dbacp05750 PTPRJ-pep19.3 CHANLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 46 ± 4.2% cell growth inhibition at 160 µM
dbacp05751 PTPRJ-pep19.3 CHANLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 51 ± 1.4% cell growth inhibition at 160 µM
dbacp05752 PTPRJ-pep19.4 CHHALTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 48.0 ± 2.82% cell growth inhibition at 160 µM
dbacp05753 PTPRJ-pep19.4 CHHALTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 62.5 ± 4.9% cell growth inhibition at 160 µM
dbacp05754 PTPRJ-pep19.4 CHHALTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 66.5 ± 2.12% cell growth inhibition at 160 µM
dbacp05755 PTPRJ-pep19.5 CHHNATHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 2 ± 1.5% cell growth inhibition at 160 µM
dbacp05756 PTPRJ-pep19.5 CHHNATHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 19 ± 4.2% cell growth inhibition at 160 µM
dbacp05757 PTPRJ-pep19.6 CHHNLAHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 19 ± 4.2% cell growth inhibition at 160 µM
dbacp05758 PTPRJ-pep19.7 CHHNLTAAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 4.5 ± 2.13% cell growth inhibition at 160 µM
dbacp05759 PTPRJ-pep19.7 CHHNLTAAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 20 ± 1.4% cell growth inhibition at 160 µM
dbacp06557 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay U-937 Lymphoma cancer IC50 : 123 µg/ml
dbacp06558 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay 8402 Leukemia cancer IC50 : 83 µg/ml
dbacp06559 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay SSKT-1 Hematopoietic cancer IC50 : 109 µg/ml
dbacp06560 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Daudi Leukemia cancer IC50 : 143 µg/ml
dbacp06561 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MLA Leukemia cancer IC50 : 102 µg/ml
dbacp06562 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay Raji Lymphoma cancer IC50 : 72 µg/ml
dbacp06563 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay K-562 Leukemia cancer IC50 : 112 µg/ml
dbacp06564 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay CHP-100 Ewing sarcoma Not found
dbacp06565 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay MCF-7 Breast cancer Not found
dbacp06566 Z24 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients; Induce osmotic lysis; Membrane damage Trypan blue assay PC-3 Prostate cancer Not found
dbacp06573 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay U-937 Lymphoma cancer IC50 : 97 µg/ml
dbacp06574 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay 8402 Leukemia cancer IC50 : 60 µg/ml
dbacp06575 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay SSKT-1 Hematopoietic cancer IC50 : 107 µg/ml
dbacp06576 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay Daudi Brain tumor IC50 : 115 µg/ml
dbacp06577 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay MLA Leukemia cancer IC50 : 80 µg/ml
dbacp06578 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay Raji Lymphoma cancer IC50 : 64 µg/ml
dbacp06579 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay K-562 Leukemia cancer IC50 : 98 µg/ml
dbacp06580 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay CHP-100 Ewing sarcoma Not found
dbacp06581 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay MCF-7 Breast cancer Not found
dbacp06582 Z44 ALSKALSKALSKALSKALSKALSK African clawed frog Dissipate ion gradients;Induce osmotic lysis; Membrane damage Trypan blue assay PC-3 Prostate cancer Not found
dbacp06773 Moricin AKIPIKAAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKA Bombyx mori Peptide-induced cell death Trypan blue assay MDA-MB-231 Triple-negative Breast Cancer 70% cell viability at 6.25 µg/ml
dbacp07343 HMP-S7 SFIPRAKSTWLNNIKLL Human Milk Membrane penetration, cytoplasmic leakage Trypan blue assay Jurkat Blood Cancer IC50 = 186 ± 37 µM
dbacp07344 HMP-S7 SFIPRAKSTWLNNIKLL Human Milk Membrane penetration, cytoplasmic leakage Trypan blue assay RS4 Blood Cancer IC50 = 184 ± 23 µM
dbacp07345 HMP-S7 SFIPRAKSTWLNNIKLL Human Milk Membrane penetration, cytoplasmic leakage Trypan blue assay Raji Lymphoma Cancer IC50 = 89 ± 24 µM
dbacp07346 HMP-S7 SFIPRAKSTWLNNIKLL Human Milk Membrane penetration, cytoplasmic leakage Trypan blue assay Sup-B15 Blood Cancer IC50 = 90 ± 14 µM